Dr Camidge and Sofia Diana Merajver, MD, PhD, reflected her lifelong journey shaped by immigration, intellectual curiosity, and a commitment to science in service of human health.
Sofia Diana Merajver, MD, PhD
Advertisement
Sofia Diana Merajver MD, PhD is the medical director of the Breast and Ovarian Cancer Risk Evaluation Program at the U-M Rogel Cancer Center.
Articles by Sofia Diana Merajver, MD, PhD
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Plinabulin Plus Docetaxel in Post-ICI Non-Squamous NSCLC
2
Breast Cancer Experts Highlight Abstracts to Watch at ESMO 2026
3
Navigating DLL3-Targeting T-Cell Engagers and the Evolving Small Cell Lung Cancer Treatment Landscape
4
LAG-3/PD-1 Blockade Aims to Tackle Immunotherapy Resistance Up Front in Nonsquamous NSCLC
5